— Know what they know.
Not Investment Advice
Also trades as: NAMS (NASDAQ) · $vol 30M

NAMSW NASDAQ

NewAmsterdam Pharma Company N.V.
1W: +11.0% 1M: -23.4% 3M: -46.0% YTD: -45.2% 1Y: -26.1% 3Y: +542.1% 5Y: +1542.9%
$12.70
+0.05 (+0.40%)
 
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 41 · $2.7B mcap · 81M float · 0.0013% daily turnover · Short 69% of daily vol

📊 Key Metrics

TTM
$7M
Revenue
-88.9% YoY
$-260M
Net Income
-56.6% YoY
$-144M
Free Cash Flow
-15.6% YoY
100.0%
Gross Margin
-1752.6%
Op. Margin
-1732.9%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-36.8%
ROA-34.2%
ROIC8216.2%

Valuation

P/E-10.6
P/B4.5
EV/EBITDA-7.9

Leverage

Debt/Equity0.00
Current Ratio9.03
Interest Cov.0.0x

Quality Scores

Piotroski F2/9
Altman Z19.73
Beneish M-4.66

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms